"To investigate the pharmacokinetics (PKs) and pharmacodynamics (PDs) for ION-353382 an antisense oligonucleotide (ASO) targeting scavenger receptor class B type I (SRB1) mRNA using alpha-2-macroglobulin (A2M) murinoglobulin double-knockout (DKO) and wild-type mice"xsd:string